✦ LIBER ✦

1149 POSTER A multicenter phase II study with docetaxel plus gemcitabine in untreated patients with advanced lung adenocarcinomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel plus gemcitabine as front-line

✍ Boukovinas, I.; Souglakos, J.; Hatzidaki, D.; Kakolyris, S.; Ziras, N.; Vamvakas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 232 KB

A phase II study of gemcitabine and cisp

✍ Lee, J K; Capanu, M; O'Reilly, E M; Ma, J; Chou, J F; Shia, J; Katz, S S; Gansuk 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 261 KB

Randomized, multicenter, phase II study

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Phase II Study of Cetuximab, Docetaxel,

✍ David R. Spigel; F. Anthony Greco; Dana S. Thompson; Charles Webb; James Rubinsa 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 129 KB

A phase II trial of gemcitabine plus cap

✍ Byeong-Bae Park; Joon Oh Park; Hyo Rak Lee; Jeeyun Lee; Dong Wook Choi; Seong-Ho 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB

Docetaxel plus cisplatin versus docetaxe

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB